- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hamilton acquires integration assets from Pontis
Hamilton Scientific, a developer of Internet-based medical applications, has purchased the assets of Pontis Medical, a developer of remote access solutions for the healthcare industry. Pontis created the eM-Net system (now called MedFreedom),
Hamilton Scientific, a developer of Internet-based medical applications, has purchased the assets of Pontis Medical, a developer of remote access solutions for the healthcare industry. Pontis created the eM-Net system (now called MedFreedom), which is designed to connect hospitals, imaging centers, and other healthcare facilities with affiliated physicians via the Internet. Hamilton intends to make MedFreedom the platform for communication and electronic transactions between physicians and the institutions they work with. Hamilton's products include myPatientCharts.com and Duet, which will be available to all physicians participating on the MedFreedom network. myPatientCharts is an XML- and Java-based application that allows the secure exchange of patient information over the Internet, while Duet is a messaging application.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
